Get Real Time Here
| Open5.860 | Close5.560 |
| Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
| Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Longboard Pharmaceuticals Stock (NASDAQ:LBPH), Quotes and News Summary
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
| Open5.860 | Close5.560 |
| Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
| Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.600 | -0.650 | -0.0500 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
| 2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Longboard Pharmaceuticals (LBPH) stock?
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Who are Longboard Pharmaceuticals's (LBPH) competitors?
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
What is the target price for Longboard Pharmaceuticals (LBPH) stock?
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Longboard Pharmaceuticals (LBPH)?
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
Does Longboard Pharmaceuticals (LBPH) pay a dividend?
There is no dividend information for Longboard Pharmaceuticals.
When is Longboard Pharmaceuticals (NASDAQ:LBPH) reporting earnings?
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Longboard Pharmaceuticals (LBPH) going to split?
There is no upcoming split for Longboard Pharmaceuticals.
What sector and industry does Longboard Pharmaceuticals (LBPH) operate in?
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ:LBPH), Quotes and News Summary
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
| Open5.860 | Close5.560 |
| Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
| Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.600 | -0.650 | -0.0500 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
| 2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Longboard Pharmaceuticals (LBPH) stock?
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Who are Longboard Pharmaceuticals's (LBPH) competitors?
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
What is the target price for Longboard Pharmaceuticals (LBPH) stock?
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Longboard Pharmaceuticals (LBPH)?
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
Does Longboard Pharmaceuticals (LBPH) pay a dividend?
There is no dividend information for Longboard Pharmaceuticals.
When is Longboard Pharmaceuticals (NASDAQ:LBPH) reporting earnings?
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Longboard Pharmaceuticals (LBPH) going to split?
There is no upcoming split for Longboard Pharmaceuticals.
What sector and industry does Longboard Pharmaceuticals (LBPH) operate in?
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ:LBPH), Quotes and News Summary
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
| Open5.860 | Close5.560 |
| Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
| Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.600 | -0.650 | -0.0500 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
| 2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Longboard Pharmaceuticals (LBPH) stock?
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Who are Longboard Pharmaceuticals's (LBPH) competitors?
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
What is the target price for Longboard Pharmaceuticals (LBPH) stock?
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Longboard Pharmaceuticals (LBPH)?
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
Does Longboard Pharmaceuticals (LBPH) pay a dividend?
There is no dividend information for Longboard Pharmaceuticals.
When is Longboard Pharmaceuticals (NASDAQ:LBPH) reporting earnings?
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Longboard Pharmaceuticals (LBPH) going to split?
There is no upcoming split for Longboard Pharmaceuticals.
What sector and industry does Longboard Pharmaceuticals (LBPH) operate in?
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ:LBPH), Quotes and News Summary
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
| Open5.860 | Close5.560 |
| Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
| Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.600 | -0.650 | -0.0500 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
| 2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Longboard Pharmaceuticals (LBPH) stock?
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Who are Longboard Pharmaceuticals's (LBPH) competitors?
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
What is the target price for Longboard Pharmaceuticals (LBPH) stock?
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Longboard Pharmaceuticals (LBPH)?
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
Does Longboard Pharmaceuticals (LBPH) pay a dividend?
There is no dividend information for Longboard Pharmaceuticals.
When is Longboard Pharmaceuticals (NASDAQ:LBPH) reporting earnings?
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Longboard Pharmaceuticals (LBPH) going to split?
There is no upcoming split for Longboard Pharmaceuticals.
What sector and industry does Longboard Pharmaceuticals (LBPH) operate in?
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ:LBPH), Quotes and News Summary
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
| Open5.860 | Close5.560 |
| Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
| Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.600 | -0.650 | -0.0500 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
| 2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Longboard Pharmaceuticals (LBPH) stock?
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Who are Longboard Pharmaceuticals's (LBPH) competitors?
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
What is the target price for Longboard Pharmaceuticals (LBPH) stock?
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Longboard Pharmaceuticals (LBPH)?
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
Does Longboard Pharmaceuticals (LBPH) pay a dividend?
There is no dividend information for Longboard Pharmaceuticals.
When is Longboard Pharmaceuticals (NASDAQ:LBPH) reporting earnings?
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Longboard Pharmaceuticals (LBPH) going to split?
There is no upcoming split for Longboard Pharmaceuticals.
What sector and industry does Longboard Pharmaceuticals (LBPH) operate in?
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ:LBPH), Quotes and News Summary
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
| Open5.860 | Close5.560 |
| Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
| Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.600 | -0.650 | -0.0500 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
| 2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Longboard Pharmaceuticals (LBPH) stock?
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Who are Longboard Pharmaceuticals's (LBPH) competitors?
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
What is the target price for Longboard Pharmaceuticals (LBPH) stock?
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Longboard Pharmaceuticals (LBPH)?
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
Does Longboard Pharmaceuticals (LBPH) pay a dividend?
There is no dividend information for Longboard Pharmaceuticals.
When is Longboard Pharmaceuticals (NASDAQ:LBPH) reporting earnings?
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Longboard Pharmaceuticals (LBPH) going to split?
There is no upcoming split for Longboard Pharmaceuticals.
What sector and industry does Longboard Pharmaceuticals (LBPH) operate in?
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ:LBPH), Quotes and News Summary
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
| Open5.860 | Close5.560 |
| Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
| Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.600 | -0.650 | -0.0500 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
| 2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Longboard Pharmaceuticals (LBPH) stock?
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Who are Longboard Pharmaceuticals's (LBPH) competitors?
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
What is the target price for Longboard Pharmaceuticals (LBPH) stock?
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Longboard Pharmaceuticals (LBPH)?
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
Does Longboard Pharmaceuticals (LBPH) pay a dividend?
There is no dividend information for Longboard Pharmaceuticals.
When is Longboard Pharmaceuticals (NASDAQ:LBPH) reporting earnings?
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Longboard Pharmaceuticals (LBPH) going to split?
There is no upcoming split for Longboard Pharmaceuticals.
What sector and industry does Longboard Pharmaceuticals (LBPH) operate in?
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ:LBPH), Quotes and News Summary
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
| Open5.860 | Close5.560 |
| Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
| Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.600 | -0.650 | -0.0500 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
| 2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Longboard Pharmaceuticals (LBPH) stock?
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Who are Longboard Pharmaceuticals's (LBPH) competitors?
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
What is the target price for Longboard Pharmaceuticals (LBPH) stock?
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Longboard Pharmaceuticals (LBPH)?
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
Does Longboard Pharmaceuticals (LBPH) pay a dividend?
There is no dividend information for Longboard Pharmaceuticals.
When is Longboard Pharmaceuticals (NASDAQ:LBPH) reporting earnings?
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Longboard Pharmaceuticals (LBPH) going to split?
There is no upcoming split for Longboard Pharmaceuticals.
What sector and industry does Longboard Pharmaceuticals (LBPH) operate in?
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ:LBPH), Quotes and News Summary
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
| Open5.860 | Close5.560 |
| Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
| Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.600 | -0.650 | -0.0500 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
| 2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Longboard Pharmaceuticals (LBPH) stock?
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Who are Longboard Pharmaceuticals's (LBPH) competitors?
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
What is the target price for Longboard Pharmaceuticals (LBPH) stock?
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Longboard Pharmaceuticals (LBPH)?
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
Does Longboard Pharmaceuticals (LBPH) pay a dividend?
There is no dividend information for Longboard Pharmaceuticals.
When is Longboard Pharmaceuticals (NASDAQ:LBPH) reporting earnings?
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Longboard Pharmaceuticals (LBPH) going to split?
There is no upcoming split for Longboard Pharmaceuticals.
What sector and industry does Longboard Pharmaceuticals (LBPH) operate in?
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.